CFDA: Draft guidance? [RSABE / ABEL]

posted by libaiyi – China, 2018-06-13 05:39 (2116 d 10:10 ago) – Posting: # 18895
Views: 6,038

Thanks for you reply.

Another question,
how to write the null hypothesis and alternative hypothesis for BE based on FDA or EMA method?

Complete thread:

UA Flag
Activity
 Admin contact
22,957 posts in 4,819 threads, 1,636 registered users;
104 visitors (0 registered, 104 guests [including 11 identified bots]).
Forum time: 14:49 CET (Europe/Vienna)

With four parameters I can fit an elephant,
and with five I can make him wiggle his trunk.    John von Neumann

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5